AGÕæÈ˹ٷ½

STOCK TITAN

Aveanna Healthcare Holdings, Inc. SEC Filings

AVAH NASDAQ

Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Medicaid reimbursement tables, nurse staffing costs, and three distinct business lines make Aveanna Healthcare’s disclosures some of the most intricate in home care. Finding where the 10-K explains pediatric private-duty margins or tracing insider sales before rate-change news can feel overwhelming.

Stock Titan solves this complexity. Our AI reads every Aveanna Healthcare SEC filing the moment it hits EDGAR, then delivers plain-English highlights. Whether you are searching for Aveanna Healthcare insider trading Form 4 transactions, need the latest Aveanna Healthcare quarterly earnings report 10-Q filing, or want Aveanna Healthcare SEC filings explained simply, we surface the numbers and context in seconds.

Here’s how investors use the platform:

  • Track Aveanna Healthcare Form 4 insider transactions real-time to see executive buys and sells alongside AI-flagged sentiment.
  • Compare segment trends with an Aveanna Healthcare earnings report filing analysis that links revenue shifts to staffing metrics pulled from 10-Qs.
  • Dive into risks in the Aveanna Healthcare annual report 10-K simplified view—Medicaid rate exposure, labor pressure, and cash-flow notes all summarized.
  • Review governance details through the Aveanna Healthcare proxy statement executive compensation snapshot.
  • Receive alerts when an Aveanna Healthcare 8-K material events explained filing announces acquisitions, credit amendments, or leadership changes.

Stop scrolling through hundreds of pages. With understanding Aveanna Healthcare SEC documents with AI, you gain immediate clarity, real-time filing updates, and the confidence to act on complete information.

Rhea-AI Summary

On 8 Aug 2025 Aveanna Healthcare Holdings Inc. (AVAH) filed a Form 8-K under Item 7.01 (Regulation FD) to furnish an updated investor presentation (Exhibit 99.1). The deck is available in the “Investors� section of the company’s website and via IR e-mail alerts. Because the material is classified as “furnished,� it is not subject to Section 18 liability and will only be incorporated into other SEC filings if specifically referenced. Aveanna reiterates that its website is a primary channel for time-critical disclosures.

  • No financial statements, earnings metrics or major transactions accompany this report.
  • The 8-K is informational only and has no immediate accounting or voting impact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
49.36%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
49.36%
Tags
quarterly report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 filing for Aveanna Healthcare Holdings (AVAH) dated 07/10/2025 discloses ownership changes by 10% owner J.H. Whitney Equity Partners VII, LLC and its affiliated funds.

  • No shares are now held directly by the reporting person; all ownership is indirect.
  • Indirect holdings remain substantial: 28,890,756 shares via J.H. Whitney VII, L.P.; 15,523,809 shares via PSA Healthcare Investment Holdings LLC; and 1,426,034 shares via PSA Iliad Holdings LLC.
  • Two transactions coded “Jâ€� (other, no consideration) were recorded on 07/10/2025: in-kind distributions of 64,773 shares from PSA Healthcare and 17,109 shares from PSA Iliad Holdings to their respective members at a price of $0.
  • The filing states these distributions were purely structural; the reporting entities disclaim beneficial ownership beyond their economic interest.

No derivative securities were involved and no purchase or sale for cash occurred. The overall economic exposure of the reporting group declined by only 81,882 shares (<0.2% of their prior holding), suggesting a minor internal reallocation rather than a traditional insider sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 highlights: On 07/10/2025, Paul R. Vigano, a 10% owner of Aveanna Healthcare Holdings (AVAH), reported two in-kind distributions of common stock from investment vehicles he oversees.

  • 64,773 shares were distributed out of PSA Healthcare Investment Holdings LLC.
  • 17,109 shares were distributed out of PSA Iliad Holdings LLC.

The transactions were coded “J,� indicating bona-fide gifts or distributions at a reported price of $0. Post-transaction, Vigano continues to hold a large indirect stake:

  • 28.9 million shares via J.H. Whitney VII, L.P.
  • 15.5 million shares via PSA Healthcare
  • 5.18 million shares via JHW Iliad Holdings LLC
  • 1.43 million shares via PSA Iliad Holdings LLC
  • 0.54 million shares via JHW Iliad Holdings II LLC

The 81,882-share reduction represents <0.2% of Vigano’s reported indirect ownership and does not involve open-market sales or cash proceeds. No derivative securities were listed. Given the minimal size relative to his overall position, the filing appears neutral in investment significance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Form 4 filing overview: Robert M. Williams Jr., identified as a 10% owner of Aveanna Healthcare Holdings, Inc. (AVAH), reported two immaterial transactions dated 07/10/2025. Both were coded �J,� indicating in-kind distributions rather than open-market trades.

  • PSA Healthcare Investment Holdings LLC distributed 64,773 AVAH common shares to its members at a stated price of $0, reducing its post-distribution position to 15,523,809 shares.
  • PSA Iliad Holdings LLC similarly distributed 17,109 shares, leaving 1,426,034 shares.

No purchases were reported, and the filing shows Mr. Williams continues to hold—through multiple J.H. Whitney-related entities—approximately 51.6 million shares indirectly. There were no direct holdings and no change to the larger positions held by J.H. Whitney VII, L.P. (28.9 million shares), JHW Iliad Holdings LLC (5.18 million), or JHW Iliad Holdings II LLC (0.54 million).

Investor takeaway: The reported movements are administrative re-allocations within affiliated funds, executed at $0 and representing less than 0.2% of the insider’s aggregate indirect stake. Because no cash sales occurred and overall exposure remains essentially unchanged, the filing is neutral from a supply-demand perspective but does increase the free-float slightly as distributed shares migrate to individual members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Aveanna Healthcare (NASDAQ: AVAH) filed an 8-K announcing a Seventh Amendment to its receivables securitization facility. The amendment raises the maximum availability to $275 million, subject to the existing borrowing-base, and extends the scheduled termination date to three years from 25 June 2025. The change strengthens near-term liquidity and pushes out maturities without adding new restrictive covenants. The full text of the amendment is filed as Exhibit 10.1.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Aveanna Healthcare Holdings (AVAH)?

The current stock price of Aveanna Healthcare Holdings (AVAH) is $6.14 as of August 8, 2025.

What is the market cap of Aveanna Healthcare Holdings (AVAH)?

The market cap of Aveanna Healthcare Holdings (AVAH) is approximately 802.4M.
Aveanna Healthcare Holdings, Inc.

NASDAQ:AVAH

AVAH Rankings

AVAH Stock Data

802.42M
48.73M
5.75%
88.27%
1.06%
Medical Care Facilities
Services-home Health Care Services
United States
ATLANTA